5712 Results

People

  1. Drilon
    Drilon
  2. Perales
    Perales
  3. Giralt
    Giralt
  4. Motzer
    Motzer
  5. Ladanyi
    Ladanyi
  6. Morrow
    Morrow
  7. Rimner
    Rimner
  8. O'Reilly
    O'Reilly
  9. Horwitz
    Horwitz
  10. Jones
    Jones

Groups

  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)
  7. Hematologic Malignancies, Division of (875)
  8. Center for Hematologic Malignancies (802)
  9. Population Sciences Research Program (786)
  10. Department of Pathology and Laboratory Medicine (677)
  1. "2021"
Formats
  1. Journal Article (2507)
  2. Meeting Abstract (1731)
  3. Review (604)
  4. Editorial (358)
  5. Book Section (123)
  6. Correspondence (107)
  7. Guidelines (103)
  8. Research Letter (91)
  9. Miscellaneous (52)
  10. Conference Paper (34)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)

More Groups

People
  1. Alexander Drilon (76)
  2. Miguel-Angel Perales (68)
  3. Sergio Giralt (66)
  4. Robert Motzer (65)
  5. Marc Ladanyi (62)
  6. Monica Morrow (57)

More People

Years
  1. 2021 (5712)
Publications
  1. Journal of Clinical Oncology (471)
  2. Blood (252)
  3. Annals of Oncology (148)
  4. Cancer Research (145)
  5. International Journal of Radiation Oncology, Biology, Physics (145)
  6. Journal of Thoracic Oncology (101)

More Publications

Publishers
  1. Elsevier Inc. (723)
  2. American Society of Clinical Oncology (522)
  3. Springer (381)
  4. Oxford University Press (360)
  5. Nature Publishing Group (344)
  6. American Association for Cancer Research (297)

More Publishers

Results (5712)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: A focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline
    Journal Article

    Hoda, R. S.; Bowman, A. S.; Zehir, A.; Razavi, P.; Brogi, E.; Ladanyi, M.; Arcila, M. E.; Wen, H. Y.; Ross, D. S.
    Histopathology (2021)

    Fulltext@MSK | Save
  • Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China
    Journal Article

    Li, Y.; Wu, J.; Wang, S.; Li, X.; Zhou, J.; Huang, B.; Luo, D.; Cao, Q.; Chen, Y.; Chen, S.; more...
    Histopathology (2021)

    Fulltext@MSK | Save
  • Genetically predicted circulating protein biomarkers and ovarian cancer risk
    Journal Article

    Considine, D. P. C.; Jia, G.; Shu, X.; Schildkraut, J. M.; Pharoah, P. D. P.; Zheng, W.; Kar, S. P.; for the Ovarian Cancer Association Consortium
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers
    Review

    Russo, S.; Walker, J. L.; Carlson, J. W.; Carter, J.; Ward, L. C.; Covens, A.; Tanner, E. J. 3rd; Armer, J. M.; Ridner, S.; Hayes, S.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events
    Journal Article

    Straubhar, A. M.; Wolf, J. L.; Zhou, Q. C.; Iasonos, A.; Cham, S.; Wright, J. D.; Long Roche, K.; Chi, D. S.; Zivanovic, O.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms
    Review

    Chiang, S.
    Genes Chromosomes and Cancer (2021)

    Fulltext@MSK | Save
  • Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's letter to the editor re: Konrad H. Stopsack. Efficacy of PARP inhibition in metastatic castration-resistant prostate cancer is very different with non-BRCA DNA repair alterations: Reconstructing prespecified endpoints for cohort B from the phase 3 PROfound trial of olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024
    Correspondence

    Stopsack, K. H.
    European Urology (2021)

    Fulltext@MSK | Save
  • Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I
    Guidelines

    Schlegel, P. N.; Sigman, M.; Collura, B.; De Jonge, C. J.; Eisenberg, M. L.; Lamb, D. J.; Mulhall, J. P.; Niederberger, C.; Sandlow, J. I.; Sokol, R. Z.; more...
    Fertility and Sterility (2021)

    Fulltext@MSK | Save
  • Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II
    Guidelines

    Schlegel, P. N.; Sigman, M.; Collura, B.; De Jonge, C. J.; Eisenberg, M. L.; Lamb, D. J.; Mulhall, J. P.; Niederberger, C.; Sandlow, J. I.; Sokol, R. Z.; more...
    Fertility and Sterility (2021)

    Fulltext@MSK | Save
  • The National Polyp Study at 40: Challenges then and now
    Review

    Winawer, S. J.; Zauber, A. G.; O'Brien, M. J.; Geenen, J.; Waye, J. D.
    Gastrointestinal Endoscopy (2021)

    Fulltext@MSK | Save